The FDA recently gained more leverage over pharmaceutical companies. Will it use it?

📆 2023/02/26 0:57:00
📰 NPRHealth

⏱ Reading Time:
1 sec. here
2 min. at publisher
📊 Quality Score:
News: 4%
Publisher: 63%

日本ニュースニュース

日本最新ニュース,日本見出し

The U.S. Food and Drug Administration late last year got more leverage over pharmaceutical companies that received accelerated approvals for their drugs. How will the agency use its new powers?

コメントを書く

Not under the Biden administration.

Worked on TecentriqHCP startup in NSCLC for North America while at PPDCRO at the end of 2014. US_FDA approved it by 2019. Wrote so many reports for GO29436, 437, 537, 432, 431, 527 got RSI. PPD wrongfully terminated me 2017 after they injured fly_BUR in 2016. You’re welcome

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。続きを読む:

日本 最新ニュース, 日本 見出し

日本最新ニュース, 日本見出し